Vincera Pharma Inc (VINC)
0.5770 x 4 0.5900 x 5
Post-market by (Cboe BZX)
0.5800 +0.0196 (+3.50%) 03/25/25 [NASDAQ]
0.5770 x 4 0.5900 x 5
Post-market 0.5753 -0.0047 (-0.81%) 16:38 ET
for Tue, Mar 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,027 | 8,005 | 5,192 | 12,854 | 15,148 |
| Marketable Securities | 7,144 | 8,396 | N/A | 0 | 5,724 |
| Receivables | 1,063 | 1,018 | 1,025 | 1,044 | 1,053 |
| Other current assets | 231 | 334 | 760 | 784 | 571 |
| TOTAL | $11,748 | $18,283 | $7,677 | $14,733 | $22,818 |
| Non-Current Assets | |||||
| PPE Net | 85 | 98 | 111 | 125 | 137 |
| Other Non-Current Assets | 3,114 | 3,146 | 3,295 | 3,359 | 3,321 |
| TOTAL | $3,199 | $3,244 | $3,406 | $3,484 | $3,458 |
| Total Assets | $14,947 | $21,527 | $11,083 | $18,217 | $26,276 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,963 | 1,536 | 2,314 | 2,497 | 3,062 |
| Accrued Expenses | 1,724 | 2,428 | 1,727 | 1,755 | 4,526 |
| Other current liabilities | 463 | 132 | 5,395 | 191 | 132 |
| TOTAL | $5,424 | $5,332 | $10,634 | $5,605 | $8,846 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 415 | 747 | 1,071 | 1,390 | 1,689 |
| TOTAL | $415 | $747 | $1,071 | $1,390 | $1,689 |
| Total Liabilities | $5,839 | $6,079 | $11,705 | $6,995 | $10,535 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,678 | 1,484 | 1,477 | 1,071 | 1,069 |
| Common Shares | 3 | 3 | 2 | 2 | 2 |
| Retained earnings | -181,192 | -173,349 | -171,541 | -159,112 | -156,545 |
| Other shareholders' equity | 104 | 24 | 60 | 8 | 52 |
| TOTAL | $9,108 | $15,448 | $-622 | $11,222 | $15,741 |
| Total Liabilities And Equity | $14,947 | $21,527 | $11,083 | $18,217 | $26,276 |